38 related articles for article (PubMed ID: 16039859)
1. Facile synthesis and antimycobacterial activity of isoniazid, pyrazinamide and ciprofloxacin derivatives.
Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
Chem Biol Drug Des; 2021 Jun; 97(6):1137-1150. PubMed ID: 33638304
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and antimycobacterial activities of 1-methyl-2-alkenyl-4(1H)-quinolones.
Wube AA; Hüfner A; Thomaschitz C; Blunder M; Kollroser M; Bauer R; Bucar F
Bioorg Med Chem; 2011 Jan; 19(1):567-79. PubMed ID: 21106378
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Evaluation of Novel Substituted N-Aryl 1,4-Dihydropyridines as Antituberculostatic Agents.
Seitz L; Reiling N; Vorreiter C; Sippl W; Kessler S; Hilgeroth A
Med Chem; 2024; 20(1):30-39. PubMed ID: 37349995
[TBL] [Abstract][Full Text] [Related]
4. Advancements in Synthetic Strategies and Biological Effects of Ciprofloxacin Derivatives: A Review.
Khwaza V; Mlala S; Aderibigbe BA
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732134
[TBL] [Abstract][Full Text] [Related]
5. Pharmacophore modeling, docking and the integrated use of a ligand- and structure-based virtual screening approach for novel DNA gyrase inhibitors: synthetic and biological evaluation studies.
Mathpal D; Masand M; Thomas A; Ahmad I; Saeed M; Zaman GS; Kamal M; Jawaid T; Sharma PK; Gupta MM; Kumar S; Srivastava SP; Balaramnavar VM
RSC Adv; 2021 Oct; 11(55):34462-34478. PubMed ID: 35494744
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A
Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and In Vitro Antimycobacterial and Antibacterial Activity of 8-OMe Ciprofloxacin-Hydrozone/Azole Hybrids.
Xu Z; Zhang S; Feng LS; Li XN; Huang GC; Chai Y; Lv ZS; Guo HY; Liu ML
Molecules; 2017 Jul; 22(7):. PubMed ID: 28703766
[TBL] [Abstract][Full Text] [Related]
8. A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides.
Chandrika NT; Garneau-Tsodikova S
Medchemcomm; 2016; 7(1):50-68. PubMed ID: 27019689
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and antitubercular activity of certain nicotinic Acid hydrazides.
Eldehna WM; Fares M; Abdel-Aziz MM; Abdel-Aziz HA
Molecules; 2015 May; 20(5):8800-15. PubMed ID: 25988611
[TBL] [Abstract][Full Text] [Related]
10. Mannich bases in medicinal chemistry and drug design.
Roman G
Eur J Med Chem; 2015 Jan; 89():743-816. PubMed ID: 25462280
[TBL] [Abstract][Full Text] [Related]
11. New 7-[4-(4-(un)substituted)piperazine-1-carbonyl]- piperazin-1-yl] derivatives of fluoroquinolone: synthesis and antimicrobial evaluation.
Chen PT; Lin WP; Lee AR; Hu MK
Molecules; 2013 Jun; 18(7):7557-69. PubMed ID: 23807580
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, in vitro antimycobacterial and antibacterial evaluation of IMB-070593 derivatives containing a substituted benzyloxime moiety.
Wei Z; Wang J; Liu M; Li S; Sun L; Guo H; Wang B; Lu Y
Molecules; 2013 Mar; 18(4):3872-93. PubMed ID: 23538901
[TBL] [Abstract][Full Text] [Related]
13. Schiff bases of indoline-2,3-dione: potential novel inhibitors of Mycobacterium tuberculosis (Mtb) DNA gyrase.
Aboul-Fadl T; Abdel-Aziz HA; Abdel-Hamid MK; Elsaman T; Thanassi J; Pucci MJ
Molecules; 2011 Sep; 16(9):7864-79. PubMed ID: 22143547
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives.
Sriram D; Yogeeswari P; Basha JS; Radha DR; Nagaraja V
Bioorg Med Chem; 2005 Oct; 13(20):5774-8. PubMed ID: 16039859
[TBL] [Abstract][Full Text] [Related]
15. Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase.
Sriram D; Aubry A; Yogeeswari P; Fisher LM
Bioorg Med Chem Lett; 2006 Jun; 16(11):2982-5. PubMed ID: 16554151
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides.
Sriram D; Yogeeswari P; Devakaram RV
Bioorg Med Chem; 2006 May; 14(9):3113-8. PubMed ID: 16412646
[TBL] [Abstract][Full Text] [Related]
17. Antimycobacterial activities of novel fluoroquinolones.
Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V; Sriram D
Biomed Pharmacother; 2009 Jan; 63(1):27-35. PubMed ID: 18031974
[TBL] [Abstract][Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
19. [Expectation of new antituberculous drugs and targeting therapy for treatment of mycobacterial infections].
Tomioka H
Kekkaku; 1993 Nov; 68(11):723-30. PubMed ID: 8264129
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
